Overview | Agenda | Faculty Materials | Registration | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home




AGENDA

National Health Policy Audioconference: The Implications of Comparative Effectiveness to Pharma, Device and Life Sciences Enterprises and Medical Practice

  • Monday, February 23, 2009
    1:00 pm - 2:30 pm (Eastern)
    12:00 pm - 1:30 pm (Central)
    11:00 am - 12:30 pm (Mountain)
    10:00 am - 11:30 am (Pacific)


The Audioconference agenda is set forth in Eastern Daylight Time below:

1:00 pm Welcome and Introductory Comments
John K. Iglehart (Moderator)

1:05 pm

Why a Comparative Effectiveness Institute is a Foundation Block for National Health Reform
Gail Wilensky, PhD
1:20 pm The Implications of Comparative Effectiveness to the Pharmaceutical Sector
Marc L. Berger, MD
1:35 pm The Implications of Comparative Effectiveness to the Device Sector
David Nexon
1:50 pm Federal Priorities in the Design and Implementation of a Comparative Effectiveness Initiative
Carolyn M. Clancy, MD

2:05 pm

Questions and Answers
John K. Iglehart (Moderator)

2:30 pm

Audioconference Adjournment




Overview | Agenda | Faculty Materials | Registration | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home




© Health Care Conference Administrators
Contact Webmaster